ES416728A2 - Glycoproteins - Google Patents

Glycoproteins

Info

Publication number
ES416728A2
ES416728A2 ES416728A ES416728A ES416728A2 ES 416728 A2 ES416728 A2 ES 416728A2 ES 416728 A ES416728 A ES 416728A ES 416728 A ES416728 A ES 416728A ES 416728 A2 ES416728 A2 ES 416728A2
Authority
ES
Spain
Prior art keywords
origin
serum
glycoproteins
obtaining
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES416728A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES416728A2 publication Critical patent/ES416728A2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Improvements introduced in the object of the main patent No. 393,796, applied for on July 30, 1971, for: "A process for obtaining a glycoprotein of human serum origin", according to which a process for obtaining histaminopexic glycoproteins of human serum origin or animal, or of placental origin, of isoelectric point 4 ± 0.2 determined by electrofocusing, which have a concentration of at least 1,000,000 histaminepexic units per mg, is characterized by subjecting a serum of human or animal origin, or a serum of placental origin, to the action of ammonium sulfate, obtain a precipitate made up of proteins, put the precipitate back into an aqueous solution, then treat this solution with phytic acid, filter and subject the filtrate containing the glycoproteins to diafiltration on a selective porosity membrane based on non-ionic polymers, separate Protein fraction retained in the diafiltration cell, then subjected to purification by carboxymethyl cellulose gel chromatography at a pH of the order of 4.2, and separate the fraction not retained on the column. (Machine-translation by Google Translate, not legally binding)
ES416728A 1972-07-10 1973-07-09 Glycoproteins Expired ES416728A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7224890A FR2191888B2 (en) 1972-07-10 1972-07-10

Publications (1)

Publication Number Publication Date
ES416728A2 true ES416728A2 (en) 1977-10-16

Family

ID=9101595

Family Applications (1)

Application Number Title Priority Date Filing Date
ES416728A Expired ES416728A2 (en) 1972-07-10 1973-07-09 Glycoproteins

Country Status (9)

Country Link
JP (1) JPS4942813A (en)
BE (1) BE802100R (en)
CA (1) CA997333A (en)
DE (1) DE2335102A1 (en)
ES (1) ES416728A2 (en)
FR (1) FR2191888B2 (en)
GB (1) GB1433365A (en)
HU (1) HU168850B (en)
NL (1) NL7309579A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1114943B (en) * 1977-12-27 1986-02-03 Sclavo Inst Sieroterapeut HUMAN CHORIONIC SOMATOMAMMOTROPINE PREPARATION PROCESS

Also Published As

Publication number Publication date
NL7309579A (en) 1974-01-14
JPS4942813A (en) 1974-04-22
FR2191888B2 (en) 1975-08-08
BE802100R (en) 1974-01-09
DE2335102A1 (en) 1974-01-24
GB1433365A (en) 1976-04-28
CA997333A (en) 1976-09-21
HU168850B (en) 1976-07-28
FR2191888A2 (en) 1974-02-08

Similar Documents

Publication Publication Date Title
ES8104412A1 (en) Process for the preparation of a purified protein hydrolysate
GB1441751A (en) Purification of albumin by thermocoagulation
FR2548670B1 (en) PROCESS FOR THE PREPARATION OF THE MAIN BLOOD HEMOLYSIS PROTEINS IN UNDENATURED FORM
JPS6461506A (en) Production of collagen fiber
GB1496726A (en) Fractionation of proteins by electrical means
Barboriak et al. Blood plasma proteins in fetal goats and sheep.
Kopp et al. Separation of iron-containing ferritin from horse-spleen into three distinct fractions by starch-gel electrophoresis
GB1312877A (en) Whey treatment process and product
ES416728A2 (en) Glycoproteins
JPS57193494A (en) Method of purifying or concentrating biologically active protein and drug therefor
Chechik et al. Identification of human thymus-leukemia-associated antigen as a low-molecular-weight form of adenosine deaminase
Davson et al. The ionic equilibrium between the aqueous humour and blood plasma of cats
ES436525A1 (en) Protein product, a process for preparation, and application of said product
ATE59144T1 (en) PROCESS FOR THE PREPARATION OF GAMMA GLOBULIN FOR INTRAVENOUS USE.
GB2003887A (en) Isolation of peptides from urine
GB1441752A (en) Preparation of human or other purified albumin
Chow The purification and properties of certain protein hormones
ES423697A1 (en) A PROCEDURE FOR PREPARING A HUMAN SERUM HAPTOGLOBIN SOLUTION.
Weiss et al. Formation of lodinated Protein in Saliva
GB1423913A (en) Purification of orgotein
ATE72830T1 (en) PROCESS FOR PRODUCTION OF PURIFIED GLUCOSE ISOMERASE.
US2603585A (en) Purification of gonadotropic hormones with a basic protein
BG31214A3 (en) Method for obtaining of human albumine
SU1170318A1 (en) Method of determining blood capillaries on histologic specimen
DE2157610B2 (en) Process for its isolation and its use for the preparation of antisera

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170704